| Literature DB >> 24920580 |
Naoto Muraoka1, Hiroyuki Yamakawa1, Kazutaka Miyamoto1, Taketaro Sadahiro1, Tomohiko Umei2, Mari Isomi2, Hanae Nakashima2, Mizuha Akiyama2, Rie Wada2, Kohei Inagawa1, Takahiko Nishiyama1, Ruri Kaneda1, Toru Fukuda3, Shu Takeda3, Shugo Tohyama4, Hisayuki Hashimoto4, Yoshifumi Kawamura5, Naoki Goshima6, Ryo Aeba7, Hiroyuki Yamagishi8, Keiichi Fukuda4, Masaki Ieda9.
Abstract
Fibroblasts can be directly reprogrammed into cardiomyocyte-like cells (iCMs) by overexpression of cardiac transcription factors or microRNAs. However, induction of functional cardiomyocytes is inefficient, and molecular mechanisms of direct reprogramming remain undefined. Here, we demonstrate that addition of miR-133a (miR-133) to Gata4, Mef2c, and Tbx5 (GMT) or GMT plus Mesp1 and Myocd improved cardiac reprogramming from mouse or human fibroblasts by directly repressing Snai1, a master regulator of epithelial-to-mesenchymal transition. MiR-133 overexpression with GMT generated sevenfold more beating iCMs from mouse embryonic fibroblasts and shortened the duration to induce beating cells from 30 to 10 days, compared to GMT alone. Snai1 knockdown suppressed fibroblast genes, upregulated cardiac gene expression, and induced more contracting iCMs with GMT transduction, recapitulating the effects of miR-133 overexpression. In contrast, overexpression of Snai1 in GMT/miR-133-transduced cells maintained fibroblast signatures and inhibited generation of beating iCMs. MiR-133-mediated Snai1 repression was also critical for cardiac reprogramming in adult mouse and human cardiac fibroblasts. Thus, silencing fibroblast signatures, mediated by miR-133/Snai1, is a key molecular roadblock during cardiac reprogramming.Entities:
Keywords: Snai1; cardiomyocyte; microRNA; reprogramming; transcription factor
Mesh:
Substances:
Year: 2014 PMID: 24920580 PMCID: PMC4198052 DOI: 10.15252/embj.201387605
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598